Gout C001
Current RMA Instruments
| Reasonable Hypothesis SOP | 59 of 2019 |
| Balance of Probabilities SOP | 60 of 2019 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 274.0,274.10,274.19,274.8,274.9
- ICD-10-AM Code: M10
Brief description
Gout is a urate crystal deposition disease that can manifest as a recurrent acute arthritis, usually involving a single joint, with asymptomatic periods between attacks. It may also manifest as chronic tophaceous gout, with arthropathy and deposition of solid urate in connective tissues, and associated inflammation and tissue destruction.
Confirming the diagnosis
Diagnosis is based on a combination of clinical, laboratory and imaging findings. In the case of acute gout this should include analysis of joint fluid for the presence of urate crystals. The diagnosis can be made by a general practitioner.
The relevant medical specialist is a rheumatologist.
Additional diagnoses covered by SOP
- Nil
Conditions excluded from SOP
- Hyperuricaemia without clinical manifestations (N.I.F.)
- Pseudogout#
# Non-SOP condition
Clinical onset
Clinical onset will generally correspond with a first acute arthritis episode, subsequently confirmed to be due to gout.
Clinical worsening
Gout can be successfully managed with medications and lifestyle changes directed at lowering urate levels. Treament can significantly reduce the development of chronic gouty arthritis and tophaceous gout. Progression of disease may indicate non-compliance with treatment.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/sops-grouped-icd-body-system/e-g/gout-c001-m10
Rulebase for gout
<h5><strong>Current RMA Instruments</strong></h5><table border="1" cellspacing="1" cellpadding="1"><tbody><tr><td><a href="http://www.rma.gov.au/assets/SOP/2019/059.pdf" target="_blank">Reasonable Hypothesis SOP</a></td><td><span>59 of 2019</span></td></tr><tr><td><a href="http://www.rma.gov.au/assets/SOP/2019/060.pdf" target="_blank">Balance of Probabilities SOP </a></td><td>60<span> of 2019</span></td></tr></tbody></table><h5>Changes from previous Instruments</h5><p><drupal-media data-entity-type="media" data-entity-uuid="ce20e6fa-e93a-45f7-a75e-e81122247ec3" data-view-mode="wysiwyg"></drupal-media></p><h5>ICD Coding</h5><ul><li>ICD-9-CM Codes: 274.0,274.10,274.19,274.8,274.9</li><li>ICD-10-AM Code: M10</li></ul><h5>Brief description</h5><p>Gout is a urate crystal deposition disease that can manifest as a recurrent acute arthritis, usually involving a single joint, with asymptomatic periods between attacks. It may also manifest as chronic tophaceous gout, with arthropathy and deposition of solid urate in connective tissues, and associated inflammation and tissue destruction.</p><h5>Confirming the diagnosis</h5><p>Diagnosis is based on a combination of clinical, laboratory and imaging findings. In the case of acute gout this should include analysis of joint fluid for the presence of urate crystals. The diagnosis can be made by a general practitioner.</p><p>The relevant medical specialist is a rheumatologist.</p><h5>Additional diagnoses covered by SOP</h5><ul><li>Nil</li></ul><h5>Conditions excluded from SOP</h5><ul><li>Hyperuricaemia without clinical manifestations (N.I.F.)</li><li>Pseudogout<sup><font face="Calibri" size="2">#</font></sup></li></ul><p><sup><font face="Calibri" size="2"># </font></sup>Non-SOP condition</p><h5>Clinical onset</h5><p>Clinical onset will generally correspond with a first acute arthritis episode, subsequently confirmed to be due to gout.</p><h5>Clinical worsening</h5><p>Gout can be successfully managed with medications and lifestyle changes directed at lowering urate levels. Treament can significantly reduce the development of chronic gouty arthritis and tophaceous gout. Progression of disease may indicate non-compliance with treatment.</p>
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/e-g/gout-c001-m10/rulebase-gout
Active systemic leukaemia
Current RMA Instruments
| Reasonable Hypothesis SOP | 59 of 2019 |
| Balance of Probabilities SOP | 60 of 2019 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 274.0,274.10,274.19,274.8,274.9
- ICD-10-AM Code: M10
Brief description
Gout is a urate crystal deposition disease that can manifest as a recurrent acute arthritis, usually involving a single joint, with asymptomatic periods between attacks. It may also manifest as chronic tophaceous gout, with arthropathy and deposition of solid urate in connective tissues, and associated inflammation and tissue destruction.
Confirming the diagnosis
Diagnosis is based on a combination of clinical, laboratory and imaging findings. In the case of acute gout this should include analysis of joint fluid for the presence of urate crystals. The diagnosis can be made by a general practitioner.
The relevant medical specialist is a rheumatologist.
Additional diagnoses covered by SOP
- Nil
Conditions excluded from SOP
- Hyperuricaemia without clinical manifestations (N.I.F.)
- Pseudogout#
# Non-SOP condition
Clinical onset
Clinical onset will generally correspond with a first acute arthritis episode, subsequently confirmed to be due to gout.
Clinical worsening
Gout can be successfully managed with medications and lifestyle changes directed at lowering urate levels. Treament can significantly reduce the development of chronic gouty arthritis and tophaceous gout. Progression of disease may indicate non-compliance with treatment.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/e-g/gout-c001-m10/rulebase-gout/active-systemic-leukaemia
Alcohol consumption
Current RMA Instruments
| Reasonable Hypothesis SOP | 59 of 2019 |
| Balance of Probabilities SOP | 60 of 2019 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 274.0,274.10,274.19,274.8,274.9
- ICD-10-AM Code: M10
Brief description
Gout is a urate crystal deposition disease that can manifest as a recurrent acute arthritis, usually involving a single joint, with asymptomatic periods between attacks. It may also manifest as chronic tophaceous gout, with arthropathy and deposition of solid urate in connective tissues, and associated inflammation and tissue destruction.
Confirming the diagnosis
Diagnosis is based on a combination of clinical, laboratory and imaging findings. In the case of acute gout this should include analysis of joint fluid for the presence of urate crystals. The diagnosis can be made by a general practitioner.
The relevant medical specialist is a rheumatologist.
Additional diagnoses covered by SOP
- Nil
Conditions excluded from SOP
- Hyperuricaemia without clinical manifestations (N.I.F.)
- Pseudogout#
# Non-SOP condition
Clinical onset
Clinical onset will generally correspond with a first acute arthritis episode, subsequently confirmed to be due to gout.
Clinical worsening
Gout can be successfully managed with medications and lifestyle changes directed at lowering urate levels. Treament can significantly reduce the development of chronic gouty arthritis and tophaceous gout. Progression of disease may indicate non-compliance with treatment.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/e-g/gout-c001-m10/rulebase-gout/alcohol-consumption
Inability to obtain appropriate clinical management for gout
Current RMA Instruments
| Reasonable Hypothesis SOP | 59 of 2019 |
| Balance of Probabilities SOP | 60 of 2019 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 274.0,274.10,274.19,274.8,274.9
- ICD-10-AM Code: M10
Brief description
Gout is a urate crystal deposition disease that can manifest as a recurrent acute arthritis, usually involving a single joint, with asymptomatic periods between attacks. It may also manifest as chronic tophaceous gout, with arthropathy and deposition of solid urate in connective tissues, and associated inflammation and tissue destruction.
Confirming the diagnosis
Diagnosis is based on a combination of clinical, laboratory and imaging findings. In the case of acute gout this should include analysis of joint fluid for the presence of urate crystals. The diagnosis can be made by a general practitioner.
The relevant medical specialist is a rheumatologist.
Additional diagnoses covered by SOP
- Nil
Conditions excluded from SOP
- Hyperuricaemia without clinical manifestations (N.I.F.)
- Pseudogout#
# Non-SOP condition
Clinical onset
Clinical onset will generally correspond with a first acute arthritis episode, subsequently confirmed to be due to gout.
Clinical worsening
Gout can be successfully managed with medications and lifestyle changes directed at lowering urate levels. Treament can significantly reduce the development of chronic gouty arthritis and tophaceous gout. Progression of disease may indicate non-compliance with treatment.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/e-g/gout-c001-m10/rulebase-gout/inability-obtain-appropriate-clinical-management-gout
Lead nephropathy
Current RMA Instruments
| Reasonable Hypothesis SOP | 59 of 2019 |
| Balance of Probabilities SOP | 60 of 2019 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 274.0,274.10,274.19,274.8,274.9
- ICD-10-AM Code: M10
Brief description
Gout is a urate crystal deposition disease that can manifest as a recurrent acute arthritis, usually involving a single joint, with asymptomatic periods between attacks. It may also manifest as chronic tophaceous gout, with arthropathy and deposition of solid urate in connective tissues, and associated inflammation and tissue destruction.
Confirming the diagnosis
Diagnosis is based on a combination of clinical, laboratory and imaging findings. In the case of acute gout this should include analysis of joint fluid for the presence of urate crystals. The diagnosis can be made by a general practitioner.
The relevant medical specialist is a rheumatologist.
Additional diagnoses covered by SOP
- Nil
Conditions excluded from SOP
- Hyperuricaemia without clinical manifestations (N.I.F.)
- Pseudogout#
# Non-SOP condition
Clinical onset
Clinical onset will generally correspond with a first acute arthritis episode, subsequently confirmed to be due to gout.
Clinical worsening
Gout can be successfully managed with medications and lifestyle changes directed at lowering urate levels. Treament can significantly reduce the development of chronic gouty arthritis and tophaceous gout. Progression of disease may indicate non-compliance with treatment.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/e-g/gout-c001-m10/rulebase-gout/lead-nephropathy
Obesity
Current RMA Instruments
| Reasonable Hypothesis SOP | 59 of 2019 |
| Balance of Probabilities SOP | 60 of 2019 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 274.0,274.10,274.19,274.8,274.9
- ICD-10-AM Code: M10
Brief description
Gout is a urate crystal deposition disease that can manifest as a recurrent acute arthritis, usually involving a single joint, with asymptomatic periods between attacks. It may also manifest as chronic tophaceous gout, with arthropathy and deposition of solid urate in connective tissues, and associated inflammation and tissue destruction.
Confirming the diagnosis
Diagnosis is based on a combination of clinical, laboratory and imaging findings. In the case of acute gout this should include analysis of joint fluid for the presence of urate crystals. The diagnosis can be made by a general practitioner.
The relevant medical specialist is a rheumatologist.
Additional diagnoses covered by SOP
- Nil
Conditions excluded from SOP
- Hyperuricaemia without clinical manifestations (N.I.F.)
- Pseudogout#
# Non-SOP condition
Clinical onset
Clinical onset will generally correspond with a first acute arthritis episode, subsequently confirmed to be due to gout.
Clinical worsening
Gout can be successfully managed with medications and lifestyle changes directed at lowering urate levels. Treament can significantly reduce the development of chronic gouty arthritis and tophaceous gout. Progression of disease may indicate non-compliance with treatment.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/e-g/gout-c001-m10/rulebase-gout/obesity
Suffering from a disease in the specified list of diseases for gout
Current RMA Instruments
| Reasonable Hypothesis SOP | 59 of 2019 |
| Balance of Probabilities SOP | 60 of 2019 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 274.0,274.10,274.19,274.8,274.9
- ICD-10-AM Code: M10
Brief description
Gout is a urate crystal deposition disease that can manifest as a recurrent acute arthritis, usually involving a single joint, with asymptomatic periods between attacks. It may also manifest as chronic tophaceous gout, with arthropathy and deposition of solid urate in connective tissues, and associated inflammation and tissue destruction.
Confirming the diagnosis
Diagnosis is based on a combination of clinical, laboratory and imaging findings. In the case of acute gout this should include analysis of joint fluid for the presence of urate crystals. The diagnosis can be made by a general practitioner.
The relevant medical specialist is a rheumatologist.
Additional diagnoses covered by SOP
- Nil
Conditions excluded from SOP
- Hyperuricaemia without clinical manifestations (N.I.F.)
- Pseudogout#
# Non-SOP condition
Clinical onset
Clinical onset will generally correspond with a first acute arthritis episode, subsequently confirmed to be due to gout.
Clinical worsening
Gout can be successfully managed with medications and lifestyle changes directed at lowering urate levels. Treament can significantly reduce the development of chronic gouty arthritis and tophaceous gout. Progression of disease may indicate non-compliance with treatment.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/e-g/gout-c001-m10/rulebase-gout/suffering-disease-specified-list-diseases-gout
Treatment with a specified drug
Current RMA Instruments
| Reasonable Hypothesis SOP | 59 of 2019 |
| Balance of Probabilities SOP | 60 of 2019 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 274.0,274.10,274.19,274.8,274.9
- ICD-10-AM Code: M10
Brief description
Gout is a urate crystal deposition disease that can manifest as a recurrent acute arthritis, usually involving a single joint, with asymptomatic periods between attacks. It may also manifest as chronic tophaceous gout, with arthropathy and deposition of solid urate in connective tissues, and associated inflammation and tissue destruction.
Confirming the diagnosis
Diagnosis is based on a combination of clinical, laboratory and imaging findings. In the case of acute gout this should include analysis of joint fluid for the presence of urate crystals. The diagnosis can be made by a general practitioner.
The relevant medical specialist is a rheumatologist.
Additional diagnoses covered by SOP
- Nil
Conditions excluded from SOP
- Hyperuricaemia without clinical manifestations (N.I.F.)
- Pseudogout#
# Non-SOP condition
Clinical onset
Clinical onset will generally correspond with a first acute arthritis episode, subsequently confirmed to be due to gout.
Clinical worsening
Gout can be successfully managed with medications and lifestyle changes directed at lowering urate levels. Treament can significantly reduce the development of chronic gouty arthritis and tophaceous gout. Progression of disease may indicate non-compliance with treatment.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/e-g/gout-c001-m10/rulebase-gout/treatment-specified-drug
Undergoing chemotherapy for a malignant tumour
Current RMA Instruments
| Reasonable Hypothesis SOP | 59 of 2019 |
| Balance of Probabilities SOP | 60 of 2019 |
Changes from previous Instruments
ICD Coding
- ICD-9-CM Codes: 274.0,274.10,274.19,274.8,274.9
- ICD-10-AM Code: M10
Brief description
Gout is a urate crystal deposition disease that can manifest as a recurrent acute arthritis, usually involving a single joint, with asymptomatic periods between attacks. It may also manifest as chronic tophaceous gout, with arthropathy and deposition of solid urate in connective tissues, and associated inflammation and tissue destruction.
Confirming the diagnosis
Diagnosis is based on a combination of clinical, laboratory and imaging findings. In the case of acute gout this should include analysis of joint fluid for the presence of urate crystals. The diagnosis can be made by a general practitioner.
The relevant medical specialist is a rheumatologist.
Additional diagnoses covered by SOP
- Nil
Conditions excluded from SOP
- Hyperuricaemia without clinical manifestations (N.I.F.)
- Pseudogout#
# Non-SOP condition
Clinical onset
Clinical onset will generally correspond with a first acute arthritis episode, subsequently confirmed to be due to gout.
Clinical worsening
Gout can be successfully managed with medications and lifestyle changes directed at lowering urate levels. Treament can significantly reduce the development of chronic gouty arthritis and tophaceous gout. Progression of disease may indicate non-compliance with treatment.
Source URL: https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/e-g/gout-c001-m10/rulebase-gout/undergoing-chemotherapy-malignant-tumour